Published: 14 September 2017
Author(s): Giuseppe Romano, Diego Bellavia, Francesco Clemenza
Section: Letter to the Editor

Usually in stable and asymptomatic patient with reduced ejection fraction the judgment to suspend or not diuretic therapy purely depend on clinical and intuitive evaluation and not on objective parameters. In clinical practice diuretic treatment in stable heart failure with reduced ejection fraction (HFrEF) patients is being used without clear evidence of major benefit on cardiovascular morbidity and mortality, due to the absence of adequately sized trials addressing these questions. In our study we support the concept that diuretics withdrawal should be performed in this HFrEF patients especially when adequate fluid balance is achieved [1].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.